BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15222994)

  • 21. First episodes of behavioral symptoms in Alzheimer's disease patients at age 90 and over, and early-onset Alzheimer's disease: comparison with senile dementia of Alzheimer's type.
    Hori K; Oda T; Asaoka T; Yoshida M; Watanabe S; Oyamada R; Tominaga I; Inada T
    Psychiatry Clin Neurosci; 2005 Dec; 59(6):730-5. PubMed ID: 16401251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Impact of music therapy on anxiety and depression for patients with Alzheimer's disease and on the burden felt by the main caregiver (feasibility study)].
    Guetin S; Portet F; Picot MC; Defez C; Pose C; Blayac JP; Touchon J
    Encephale; 2009 Feb; 35(1):57-65. PubMed ID: 19250995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous positive airway pressure reduces subjective daytime sleepiness in patients with mild to moderate Alzheimer's disease with sleep disordered breathing.
    Chong MS; Ayalon L; Marler M; Loredo JS; Corey-Bloom J; Palmer BW; Liu L; Ancoli-Israel S
    J Am Geriatr Soc; 2006 May; 54(5):777-81. PubMed ID: 16696743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease: results of a 52-week open-label study.
    Aupperle PM; Koumaras B; Chen M; Rabinowicz A; Mirski D
    Curr Med Res Opin; 2004 Oct; 20(10):1605-12. PubMed ID: 15462693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of sleep disturbance in Alzheimer's disease.
    McCurry SM; Reynolds CF; Ancoli-Israel S; Teri L; Vitiello MV
    Sleep Med Rev; 2000 Dec; 4(6):603-628. PubMed ID: 12531038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up.
    Bonanni L; Thomas A; Tiraboschi P; Perfetti B; Varanese S; Onofrj M
    Brain; 2008 Mar; 131(Pt 3):690-705. PubMed ID: 18202105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Practical treatment strategies for patients with Alzheimer's disease.
    Christensen DD; Lin P
    J Fam Pract; 2007 Dec; 56(12 Suppl New):S17-23. PubMed ID: 18664338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recommendations for best practices in the treatment of Alzheimer's disease in managed care.
    Fillit HM; Doody RS; Binaso K; Crooks GM; Ferris SH; Farlow MR; Leifer B; Mills C; Minkoff N; Orland B; Reichman WE; Salloway S
    Am J Geriatr Pharmacother; 2006; 4 Suppl A():S9-S24; quiz S25-S28. PubMed ID: 17157793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia.
    Roth T; Walsh JK; Krystal A; Wessel T; Roehrs TA
    Sleep Med; 2005 Nov; 6(6):487-95. PubMed ID: 16230048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insomnia and daytime napping in older adults.
    Ancoli-Israel S; Martin JL
    J Clin Sleep Med; 2006 Jul; 2(3):333-42. PubMed ID: 17561549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of Galantamine on sleep quality in Thai Alzheimer's disease patients.
    Chankrachang S; Senanarong V; Poungvarin N; Phanthumchinda K; Tavichachart N; Praditsuwan R; Nidhinandana S
    J Med Assoc Thai; 2008 Sep; 91(9):1343-9. PubMed ID: 18843862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults and in older adults 55+ years of age.
    Irwin MR; Cole JC; Nicassio PM
    Health Psychol; 2006 Jan; 25(1):3-14. PubMed ID: 16448292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Characteristic and treatment of insomnia in dementia].
    Nakamura M; Inoue Y
    Nihon Rinsho; 2013 Jun; 71(6):1121-7. PubMed ID: 23855224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Depression and frontal dysfunction: risks for the elderly?].
    Thomas P; Hazif Thomas C; Billon R; Peix R; Faugeron P; Clément JP
    Encephale; 2009 Sep; 35(4):361-9. PubMed ID: 19748373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonpharmacological and pharmacological interventions for symptoms in Alzheimer's disease.
    Overshott R; Byrne J; Burns A
    Expert Rev Neurother; 2004 Sep; 4(5):809-21. PubMed ID: 15853508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors associated with caregiver reports of sleep disturbances in persons with dementia.
    McCurry SM; Vitiello MV; Gibbons LE; Logsdon RG; Teri L
    Am J Geriatr Psychiatry; 2006 Feb; 14(2):112-20. PubMed ID: 16473975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The neurobiology of neuropsychiatric syndromes in dementia.
    Meeks TW; Ropacki SA; Jeste DV
    Curr Opin Psychiatry; 2006 Nov; 19(6):581-6. PubMed ID: 17012935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anxiety and nighttime behavioral disturbances. Awakenings in patients with Alzheimer's disease.
    McCurry SM; Gibbons LE; Logsdon RG; Teri L
    J Gerontol Nurs; 2004 Jan; 30(1):12-20. PubMed ID: 14753054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvement in behavioral symptoms and advance of activity acrophase after short-term bright light treatment in severe dementia.
    Skjerve A; Holsten F; Aarsland D; Bjorvatn B; Nygaard HA; Johansen IM
    Psychiatry Clin Neurosci; 2004 Aug; 58(4):343-7. PubMed ID: 15298644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacological treatment of insomnia].
    Wichniak A; Murawiec S; Jernajczyk W
    Psychiatr Pol; 2006; 40(3):563-77. PubMed ID: 17037820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.